Manuscripts
Showing 1590 manuscripts.
Allocation of family responsibility for illness management in pediatric HIV.
Citation
Sylvie Naar-King, M.D., Ph.D., Grace Montepiedra, Ph.D., Sharon L. Nichols, Ph.D., John J. Farley, M.D., M.P.H., Patricia A. Garvie, Ph.D., Betsy Kammerer, Ph.D., Kathleen Malee, Ph.D., Patricia Sirois, Ph.D., Deborah S. Storm, R.N.,Ph.D. Allocation of family responsibility for illness management in pediatric HIV. Journal of Pediatrics. 2009 Mar 01; 34(2):187-94. PMID: 18586756; PMCID: PMC2722122.Year
2009
Journal
Journal of Pediatrics
Study
P1042S
Impact of disclosure of HIV infection on health-related quality of life among children and adolescents with HIV infection.
Citation
Anne Butler, M.S., Paige L. Williams, Ph.D., Lois C. Howland, M.S., M.P.H., D.Ph., Deborah S. Storm, R.N.,Ph.D, Nancy Hutton, M.D., George Seage, III, Sc.D., M.P.H. Impact of disclosure of HIV infection on health-related quality of life among children and adolescents with HIV infection. Pediatrics. 2009 Mar 11; 123(3):935-43. PMID: 19255023; PMCID: PMC2697844.Year
2009
Journal
Pediatrics
Morphologic and Metabolic Abnormalities in Vertically HIV-infected Children and Youth: Pediatric AIDS Clinical Trials Group P1045 team
Citation
Grace M. Aldrovandi, MD, Jane C. Lindsey, Sc.D., Denise L. Jacobson, Amanda Zadzilka, B.S., Elizabeth Sheeran, M.S., R.D., John ( Jack ) Moye, Jr., M.D., Peggy R. Borum, Ph.D., William A. Meyer, III, Ph.D., Dana S. Hardin, M.D., Kathleen Mulligan, Ph.D. Morphologic and Metabolic Abnormalities in Vertically HIV-infected Children and Youth: Pediatric AIDS Clinical Trials Group P1045 team. AIDS. 2009 Mar 27; 23(6):661-72. PMID: 19279441; PMCID: PMC2680185.Year
2009
Journal
AIDS
Study
P1045
Using Social Networks to Recruit an HIV Vaccine Preparedness Cohort
Citation
Thomas Valente, Ph.D., Jennifer B. Zogg, Ph.D., Jean Richardson, Ph.D., Andrea Kovacs, M.D., Eva A. Operskalski, Ph.D., M.B.A. Using Social Networks to Recruit an HIV Vaccine Preparedness Cohort. Journal of Acquired Immune Deficiency Syndromes. 2009 Dec 01; 52(4):514-23. PMID: 19584741; PMCID: PMC2783777.Year
2009
Journal
Journal of Acquired Immune Deficiency Syndromes
Abacavir pharmacokinetics during chronic therapy in HIV-1-infected adolescents and young adults.
Citation
John W. Sleasman, M.D., Brian Robbins, Ph.D., Shane Cross, Pharm.D., Jane C. Lindsey, Sc.D., Barbara E. Heckman, B.S., H.G. Sprenger, M.D., Nancy Tustin, M.L.T., (ASCP), Charles Rose, Gary E. Pakes, Pharm.D., Edmund Capparelli, Pharm.D., P Poston, E Neal, M Nikanjam. Abacavir pharmacokinetics during chronic therapy in HIV-1-infected adolescents and young adults. Clinical Pharmacology & Therapeutics. 2009 Apr 01; 85(4):394-401. PMID: 19118380; PMCID: PMC2767189.Year
2009
Journal
Clinical Pharmacology & Therapeutics
Study
P1052
Human immunodeficiency virus type-1 infection inhibits autophagy.
Citation
Dejiang Zhou, Stephen A. Spector, M.D. Human immunodeficiency virus type-1 infection inhibits autophagy. AIDS. 2009 Mar 30; 22(6):695-9. PMID: 18356598; PMCID: PMC2764485.Year
2009
Journal
AIDS
Increased risk of hepatotoxicity in HIV-infected pregnant women receiving antiretroviral therapy independent of nevirapine exposure
Citation
David W Ouyang, David E Shapiro, Ming Lu, Susan B Brogly, Audrey L French, Robert M Leighty, Bruce Thompson, Ruth E Tuomala, Ronald C Hershow. Increased risk of hepatotoxicity in HIV-infected pregnant women receiving antiretroviral therapy independent of nevirapine exposure. AIDS. 2009 Nov 27; 23(18):2425-30. PMID: 19617813; PMCID: PMC2783653.Year
2009
Journal
AIDS
Study
P1025
Improvement in lipid profiles over 6 years of follow-up in adults with AIDS and immune reconstitution
Citation
Paige L. Williams, Ph.D., Julia (Wei) Wu, M.S., Susan Ellen Cohn, M.D., M.P.H., Susan L. Koletar, M.D., J. Allen McCutchan, M.D., M.Sc., Robert L. Murphy, M.D., Judith Silverstein Currier, M.D., M.Sc. Improvement in lipid profiles over 6 years of follow-up in adults with AIDS and immune reconstitution. HIV Medicine. 2009 May 01; 10(5):290-301. PMCID: PMC2778216.Year
2009
Journal
HIV Medicine
Predictive value of pharmacokinetics-adjusted phenotypic susceptibility on response to ritonavir-enhanced protease inhibitors (PIs) in human immunodeficiency virus-infected subjects failing prior PI therapy
Citation
Joseph J. Eron, Jr., M.D., Jeong-Gun Park, Ph.D., Richard H. Haubrich, M.D., Francesca Aweeka, Pharm.D., Barbara Bastow, R.N., B.S.N., Gary E. Pakes, Pharm.D., Song Yu, M.S., Hulin Wu, Ph.D., Douglas D. Richman, M.D. Predictive value of pharmacokinetics-adjusted phenotypic susceptibility on response to ritonavir-enhanced protease inhibitors (PIs) in human immunodeficiency virus-infected subjects failing prior PI therapy. Antimicrobial Agents and Chemotherapy. 2009 Mar 23; 53(6):2335-41. PMCID: PMC2687257.Year
2009
Journal
Antimicrobial Agents and Chemotherapy
Selegiline and oxidative stress in HIV-associated cognitive impairment
Citation
Giovanni Schifitto, M.D., Constantin Yiannoutsos, Ph.D., Thomas Ernst, Ph.D., Bradford A. Navia, M.D., Avindra Nath, M.D., Ned Sacktor, M.D., Cheryl L. Anderson, Christina M. Marra, M.D., David B. Clifford, M.D. Selegiline and oxidative stress in HIV-associated cognitive impairment. Neurology. 2009 Dec 08; 73(23):1975-81. PMCID: PMC2790227.Year
2009
Journal
Neurology